TiE Boston to Bestow Lifetime Achievement Award to Technology Entrepreneur Amar Sawhney

His inventions include several “first of a kind” surgical sealants to be approved by the United States Food and Drug Adm...

BOSTON—TiE Boston, one of the region’s largest business organizations supporting the Massachusetts entrepreneurial ecosystem, announced that it will bestow its annual Lifetime Achievement Award to serial medical technology entrepreneur Amar Sawhney at the TiE Boston gala this week.

The black-tie gala, which will take place on Thursday, Dec. 13, at the Four Seasons Boston, will also honor 14 recipients of its 2018 Entrepreneurship Awards. These awards highlight the achievements of innovators and entrepreneurs across categories such as venture capital, digital health, B2B & B2C technology and robotics and automation, TiE Boston said in a statement.

Lifetime Achievement Award Honoree Mr. Sawhney is one of the foremost innovators and entrepreneurs in medical technology. He currently serves as the Chairman of Ocular Therapeutix, Inc. and of Instylla, Inc. Previously, he served as Chairman of Augmenix, Inc., which was acquired by Boston Scientific in September 2018 for $600 million. Prior to that, Mr. Sawhney founded Confluent Surgical (acquired by Covidien), Focal Inc. (acquired by Genzyme), and Access Closure, Inc. (acquired by Cardinal Health). His innovations are the subject of over 120 issued and pending patents in biomaterials and bio-surgery...

...What motivates Mr. Sawhney to excel at everything he does?

“I don’t profess to be a perfectionist, but I am persistent,” says Mr. Sawhney. “When I take on a mission, I ensure that it reaches a logical conclusion, with not only the best possible financial outcome, but also the best outcome for patients and the team.”

His mantra for success is simple. “In my area of focus, which is medical innovation and entrepreneurship, I employ a value system. At the apex is identifying a genuine unmet need, or a worthwhile cause to focus on,” says Mr. Sawhney. “Next comes the right people to onboard for the journey, with the right values.  And finally, we need to be good stewards of capital, to generate value for our shareholders.”...

...Mr. Sawhney currently serves on the board of directors of EcoSikh, Axtria, Imperative care, Instylla and Ocular Therapeutix, where he is also a founder of the latter two companies. Through his family foundation, Mr. Sawhney has been active in charitable causes that are dear to him, which include education, wildlife and the environment, with a focus on India.

Mr. Sawhney has been recognized for his contributions in innovation and philanthropy with several awards including being named a “Champion of Change” by the White House and “Outstanding American by Choice” by the US Citizenship and Immigration Service,  “Five Most Innovative Medical Device CEOs” by MassDevice, MassMedic’s best startup company award, the Frost and Sullivan Product innovation award, MIT Global Indus Technovators Award, the E&Y Regional Entrepreneur of the Year award, Mass High Tech All Star award, New England Choice Awards, The Immigrant Entrepreneur Award, Indian Institute of Delhi’s Distinguished Alumni Award, and the University of Texas’s Outstanding Young Engineering Graduate award.

Mr. Sawhney holds an M.S. and a Ph.D. in Chemical Engineering from the University of Texas at Austin and a B. Tech. in Chemical Engineering from the Indian Institute of Technology, New Delhi...

 

Add a Comment